Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Plot No. 19-III, Opp. Bharatiya Vidya Bhavan Public School, Road No. 71, Jubilee Hills
Hyderabad; Andhra Pradesh; Map
Postal Code: 500096
Tel: 6628
Fax: 2355
Email: @smspharma.com
Website: http://www.smspharma.com

Full name: SMS Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2036172
IN-CIN: L24239AP1987PLC008066
ISIN: INE812G01017
Incorporation Date: 1987

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Intermediates & Other Products, Bulk Drugs,
More

Company Description

SMS Pharmaceuticals Ltd. is a global player in API manufacturing industry. The company's products include Anti-Ulcer, Anti-fungal, Anti-migraine, Anti- Hypertensive,etc. Incorporated in 1987, SMS Pharma is based in Hyderabad.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 88.90
Volume 25,675
Turnover 2,301,122
Index
Market Bombay Stock Exchange
Ticker EQSMSPHARMA
Market Cap Market Cap 7,517,100
52 Week High 113.85
52 Week Low 76.65
Price to Earnings (P/E) 18.05
Earnings per Share (EPS) 4.83
Dividend Yield 1 (August 30, 2010)
Bookvalue 2,847,400
Enterprise Value 8,908,555
Quote updated on January 18, 2017
Note: data in INR Thousands.

Export-Import

2013: Imports INR 409,445,262,000.00 Thousands
Import connections ('000)
Total(6,614,945,183.13)
2013: Exports INR 1,102,219,221,000.00 Thousands
Export connections ('000)
Total(17,807,312,486.87)

Key Executives

Vice President - Operations

Ownership Details

Indian Promoters
67.6%

Key Stats

Select Items to chart them. 2017 Q2C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets N/A
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest